ATH 0.00% 0.3¢ alterity therapeutics limited

PBT2 as an Antiobiotic?, page-3

  1. 2,843 Posts.
    lightbulb Created with Sketch. 996
    Here are the authors and where they work, no ATH people but in any case PBT2 and a new patent was filed over 1 year ago. Thanks pierre !

    Author Information

    1. Nichaela Harbison-Pricea,
    2. Scott A. Fergusona,
    3. Adam Heikala,
    4. George Taiaroaa,
    5. Kiel Hardsa,
    6. Yoshio Nakatania,
    7. David Rennisonb,
    8. Margaret A. Brimbleb,
    9. Ibrahim M. El-Deebc,
    10. Lisa Bohlmannd,
    11. Christopher A. McDevitte,
    12. Mark von Itzsteinc,
    13. Mark J. Walkerd and
    14. Gregory M. Cooka
    1. aDepartment of Microbiology and Immunology, University of Otago, Dunedin, New Zealand
    2. bSchool of Chemical Sciences, University of Auckland, Auckland, New Zealand
    3. cInstitute for Glycomics, Griffith University, Queensland, Australia
    4. dSchool of Chemistry and Molecular Biosciences, Australian Infectious Diseases Research Centre, The University of Queensland, Queensland, Australia
    5. eDepartment of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia

 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.4¢ 0.4¢ 0.3¢ $8.021K 2.111M

Buyers (Bids)

No. Vol. Price($)
40 23398919 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 132896552 36
View Market Depth
Last trade - 16.10pm 11/10/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.